NCT01465048 Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and Syringe Status COMPLETED Phase NA
NCT01464138 Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children Status COMPLETED Phase PHASE2
NCT01464125 Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults Status UNKNOWN Phase PHASE2
NCT01459146 Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana Status UNKNOWN Phase PHASE4
NCT01456858 Insecticide Treated Polyethylene Sheeting for Prevention of Malaria in Emergencies Status COMPLETED Phase PHASE3
NCT01454752 Intermittent Parasite Clearance (IPC) in Schools: Impact on Malaria, Anaemia and Cognition Status COMPLETED Phase NA
NCT01450293 AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Children in a Malaria Endemic Area Status COMPLETED Phase PHASE1
NCT01450280 Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CS Status COMPLETED Phase PHASE1
NCT01449045 Trial of Malaria Seasonal IPTc Combined With Community Case Management Status COMPLETED Phase PHASE3
NCT01445938 Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria Status TERMINATED Phase PHASE2
NCT01434381 Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark) Status COMPLETED Phase PHASE1
NCT01425073 Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya Status COMPLETED Phase NA
NCT01422954 Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis Status COMPLETED Phase NA
NCT01403350 Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan Status COMPLETED Phase PHASE4
NCT01397227 A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model Status COMPLETED Phase PHASE1/PHASE2